A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer. https://t.co/MO8p6Se2lG
1,219 followers
19,274 followers
#JITC Research: A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer https://t.co/d66DZLpjIs https://t.co/nRtKdlNdLn
41 followers
RT @sitcancer: #JITC Research: A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and poten…
19,274 followers
#JITC Research: A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer https://t.co/d66DZLpjIs https://t.co/RLwaz3LU2K